Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Crohn's Disease, Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06180382
What this trial is testing

Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.

Who this might be right for
Crohn's Disease
Centre Hospitalier Universitaire de Saint Etienne 220
Large-scale testing (Phase 3)Study completedNCT00152490
What this trial is testing

Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)

Who this might be right for
Crohn's Disease
UCB Pharma 604
Large-scale testing (Phase 3)Study completedNCT00300118
What this trial is testing

Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
Dr. Falk Pharma GmbH 311
Large-scale testing (Phase 3)Study completedNCT02914561
What this trial is testing

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Lakefront Biotherapeutics NV 1,372
Testing effectiveness (Phase 2)Study completedNCT01714726
What this trial is testing

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

Who this might be right for
Crohn's Disease
AstraZeneca 121
Not applicableLooking for participantsNCT07670975
What this trial is testing

Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)

Who this might be right for
Crohn Disease ColitisColitis, UlcerativeInflammatory Bowel Diseases
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06063967
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

Who this might be right for
Crohn's Disease
AbbVie 289
Not applicableStudy completedNCT03654482
What this trial is testing

SuperSeton Pilot Studie

Who this might be right for
Perianal FistulaPerianal Crohn Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60
Testing effectiveness (Phase 2)Study completedNCT00265122
What this trial is testing

The Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease

Who this might be right for
Crohn Disease
Centocor, Inc. 131
Large-scale testing (Phase 3)Study completedNCT00269854
What this trial is testing

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease

Who this might be right for
Crohn Disease
Centocor, Inc. 108
Testing effectiveness (Phase 2)Study completedNCT00771667
What this trial is testing

Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy

Who this might be right for
Crohn's Disease
Centocor, Inc. 526
Large-scale testing (Phase 3)Study completedNCT00989573
What this trial is testing

A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Otsuka Pharmaceutical Co., Ltd. 191
Testing effectiveness (Phase 2)Study completedNCT00454545
What this trial is testing

Atorvastatin in Moderate Active Crohns Disease

Who this might be right for
Crohns Disease
Skane University Hospital 12
Large-scale testing (Phase 3)UnknownNCT01817972
What this trial is testing

Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease

Who this might be right for
Crohn's Disease
Gastroenterology Research of America 65
Large-scale testing (Phase 3)Study completedNCT01661257
What this trial is testing

Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α Therapy

Who this might be right for
Crohn's Disease
Samsung Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT00731172
What this trial is testing

A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease

Who this might be right for
Crohns Disease
Tel-Aviv Sourasky Medical Center 50
Not applicableStudy completedNCT06448819
What this trial is testing

Real-life Use of the Crohn's Disease Exclusion Diet (CDED) in Adult Patients With Crohn's Disease

Who this might be right for
Crohn Disease
Universita degli Studi di Genova 45
Not applicableTemporarily pausedNCT04211129
What this trial is testing

Effect of Acupuncture on Patients With Crohn's Disease in Remission

Who this might be right for
Crohn DiseaseInflammatory Bowel Diseases
Shanghai Institute of Acupuncture, Moxibustion and Meridian 60
Large-scale testing (Phase 3)Study completedNCT00509639
What this trial is testing

Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease

Who this might be right for
Crohn's Disease
S.L.A. Pharma AG 74
Not applicableActive Not RecruitingNCT05354609
What this trial is testing

DWI MR-enterography Without or With Bowel Cleansing to Assess Intestinal Inflammatory Activity in the Follow-up of Crohn's Disease

Who this might be right for
Crohn DiseaseBowel CleansingApparent Diffusion Coefficient
Centre Hospitalier Universitaire, Amiens 140
Next Page